Identification and validation of a gene expression signature that predicts outcome in malignant glioma patients

By Kawaguchi Atsushi   Yajima Naoki   Komohara Yoshihiro   Aoki Hiroshi   Tsuchiya Naoto   Homma Jumpei   Sano Masakazu   Natsumeda Manabu   Uzuka Takeo   Saitoh Akihiko   Takahashi Hideaki   Sakai Yuko   Takahashi Hitoshi   Fujii Yukihiko   Kakuma Tatsuyuki   Yamanaka Ryuya  

International Journal of Oncology, Vol. 40, Iss. 3, 2012-03 ,pp. : 721-730

Spandidos Publications

Access to resources Recommend Favorite

Blood-based biomarkers for malignant gliomas

By Holdhoff Matthias  

Journal of Neuro-Oncology, Vol. 113, Iss. 3, 2013-07 ,pp. : 345-352

Springer Publishing Company

Access to resources Recommend Favorite

Expression and clinical significance of EGFL7 in malignant glioma

By Huang Chun-hai   Li Xue-jun   Zhou Yi-zeng   Luo Yong   Li Cui   Yuan Xian-rui  

Journal of Cancer Research and Clinical Oncology, Vol. 136, Iss. 11, 2010-11 ,pp. : 1737-1743

Springer Publishing Company

Access to resources Recommend Favorite

Phase 1 clinical trial of bortezomib in adults with recurrent malignant glioma

By Phuphanich Surasak   Supko Jeffrey   Carson Kathryn   Grossman Stuart   Burt Nabors L.   Mikkelsen Tom   Lesser Glenn   Rosenfeld Steve   Desideri Serena   Olson Jeffrey  

Journal of Neuro-Oncology, Vol. 100, Iss. 1, 2010-10 ,pp. : 95-103

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Development of Experimental Virus-Mediated Gene Therapy for Malignant Glioma

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 11, Iss. 8, 2011-10 ,pp. : 739-747

Bentham Science Publishers

Access to resources Recommend Favorite